Tag: Zonisamide

In 2021, approximately 2.9 million U.S. adults reported having active epilepsy [1.9.2, 1.9.3]. For those navigating treatment options, a common question arises: is lacosamide the same as zonisamide? The direct answer is no; they are distinct medications with different properties, uses, and side effects [1.2.1].

Studies show that approximately 1 in 7 cases of psychosis in people with epilepsy may be triggered by their medication [1.2.1]. This raises the critical question for patients and clinicians: which antiepileptic causes psychosis and what are the associated risk factors?

An estimated 50 million people worldwide have epilepsy, a common neurological disease [1.9.3]. A specific class of drugs, known as carbonic anhydrase inhibitors, represents one pathway for treatment. This article explains **how do carbonic anhydrase inhibitors treat epilepsy?**

Seizures are one of the most frequent neurological disorders in newborns, with an incidence of 1–3 per 1,000 live births [1.3.3]. While historically a primary treatment, the focus has shifted to what replaces phenobarbital due to its side-effect profile.